Evidence map›Paper›PMID 41567174›Full record

ArticleACS catalysis2026

An Integrated

Hui-Qing Geng, Álvaro Velasco-Rubio, Eva Jaramillo-Cassà, Daniel Kócsi, Pablo García-Losada, Oscar de Frutos, Ruben Martin

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS catalysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Visible Light-Driven Copper-Catalyzed Asymmetric Synthesis via Sequential C(spAngewandte Chemie (International ed. in English) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hui-Qing GengInstitute of Chemical Research of Catalonia (ICIQ), The Barcelona Institute of Science and Technology, Av. Països Catalans 16, 43007 Tarragona, Spain.
Álvaro Velasco-RubioInstitute of Chemical Research of Catalonia (ICIQ), The Barcelona Institute of Science and Technology, Av. Països Catalans 16, 43007 Tarragona, Spain.
Eva Jaramillo-CassàInstitute of Chemical Research of Catalonia (ICIQ), The Barcelona Institute of Science and Technology, Av. Països Catalans 16, 43007 Tarragona, Spain.
Daniel KócsiInstitute of Chemical Research of Catalonia (ICIQ), The Barcelona Institute of Science and Technology, Av. Països Catalans 16, 43007 Tarragona, Spain.
Pablo García-LosadaCentro de Investigación Lilly SA, Avda de la Industria 30, 28108 Alcobendas-Madrid, Spain.
Oscar de FrutosCentro de Investigación Lilly SA, Avda de la Industria 30, 28108 Alcobendas-Madrid, Spain.
Ruben MartinInstitute of Chemical Research of Catalonia (ICIQ), The Barcelona Institute of Science and Technology, Av. Països Catalans 16, 43007 Tarragona, Spain.ORCID https://orcid.org/0000-0002-2543-0221

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Herein, we describe an integrated diacylation/acylation platform that formally converts simple ketones into their

Indexed as

carbon isotope exchangeC−C bond-cleavagedrug discoveryisotope-labelingNi catalysisproaromatic precursors

Identifiers

PMID41567174
PMCPMC12817308

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.